Atlas Trials

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression

Clinical trial NCT04029428 · UNKNOWN

Trial details

NCT number
NCT04029428
Sponsor
University of Warmia and Mazury
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2004-11-02
Primary completion
2021-01-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.